However, continued efforts to prove the ability of pulchrin A targeting Bcl-2-regulated apoptosis as well as further in vivo animal studies should be conducted to provide more evidence to the anticancer effect of pulchrin A on ovarian cancer. The gene discussed is BCL2; the disease is ovarian cancer.